Jerry Rosenbaum

Jerry Rosenbaum began their work experience in 1974 as a Resident at Massachusetts General Hospital, where they eventually became the Chief of Clinical Psychopharmacology Unit and Associate Chief for Clinical Research. Jerry held the position of Stanley Cobb Professor of Psychiatry from 1998 until their departure in 2019. In 2002, Rosenbaum became the Chief of Psychiatry at Massachusetts General Hospital and the Stanley Cobb Professor of Psychiatry at Harvard Medical School until 2019. During their tenure, they oversaw a department of 600 clinicians and researchers, as well as 150 trainees. In 2020, they joined the Massachusetts General Hospital Research Institute as the Director of the Center for the Neuroscience of Psychedelics. Jerry also co-founded and served as a director for companies such as Entheos Labs, Psy Therapeutics, Inc, and Sensorium Therapeutics.

Jerry Rosenbaum attended Yale College from 1965 to 1969, where they obtained a Bachelor of Arts degree in American Studies. Subsequently, from 1969 to 1973, they enrolled at the Yale University School of Medicine, although no specific degree or field of study was mentioned.